GSM Foils Ltd Q2 FY26 – From Blister Wraps to Blistering Growth: ₹58 Cr Sales, ₹4.39 Cr PAT, and a Rights Issue Worth Discussing
1. At a Glance
Once in a while, a small-cap packaging company sneaks up on Dalal Street like a ninja with aluminum armor. GSM Foils Ltd — born in 2019, listed in 2024 — just delivered a quarter that makes most startups look like they’re still trying to open Excel. The Thane-based foil-maker posted ₹58.1 crore in sales and ₹4.39 crore PAT in Q2 FY26, marking a 107% YoY jump in profit and 86.5% surge in revenue.
At ₹191 per share (as of Dec 8, 2025), GSM sports a market cap of ₹269 crore and a P/E ratio of 18.7x, which is actually cheaper than the packaging industry median of ~20x. ROE? A jaw-dropping 45.7%, meaning for every ₹100 of equity, management pulls a “₹46 profit party.” ROCE? 45.6% — because apparently, this company believes in making both its debt and equity work overtime.
Promoters still hold 66.5%, though they recently reduced their grip (down from 73.14%), presumably to fund expansion or maybe to buy more foil to wrap their profits. The firm recently raised ₹23 crore via rights issue at ₹180 per share and bagged a ₹20 crore working capital loan from DCB Bank. So yes — they’re aggressively wrapping both tablets and balance sheets in fresh foil.
2. Introduction
Welcome to the world of GSM Foils Ltd, where aluminum isn’t just for kitchen leftovers — it’s for pharmaceutical profit. Founded just before the pandemic, this Thane-based company has managed to achieve what most young firms dream of: going from manufacturing blister foils to delivering blistering financials.
The company’s story reads like a mix between a pharmaceutical love letter and a Bollywood rags-to-riches script. In just six years, GSM has expanded from a 15,000 sq ft plant in Thane to setting up a new 17,000 sq ft unit in Sanand, Ahmedabad. Because nothing screams “expansion” like two foil factories running full throttle.
The stock itself has been on a dramatic ride — up 85% over the last year, down 21% in the last 3 months (some profit booking post the rights issue), and still trading at a multiple that suggests investors believe this foil-maker is India’s next pharma-packaging poster child.
While big names like Uflex, TCPL Packaging, and EPL Ltd dominate the packaging headlines, GSM Foils is quietly writing its own fairy tale — one coated with nitrocellulose lacquer and high tensile strength.
3. Business Model – WTF Do They Even Do?
GSM Foils Ltd is in the business of manufacturing Blister and Aluminium Pharma Foils, crucial components in pharmaceutical packaging. Think of every pill or capsule you’ve ever popped — chances are, that protective silver sheet was someone like GSM’s handiwork.
Here’s the layman version:
Blister Foils – These are the push-through or peel-push packs used for tablets and capsules. GSM makes variants like Push-Through, Peel-Open, Tear-Open, etc.
Aluminium Strip Pharma Foils – These foils offer full barrier protection (light, air, moisture, bacteria) for sensitive drugs.
Both product lines rely heavily on precision lamination, coating, and printing technology, and GSM has been ramping up capacity through modern machinery — new rotogravure printing and lamination machines worth over ₹1.6 crore in total capex since 2024.
Their key clients? Pharma manufacturers. Their core business model? B2B manufacturing and supply. And their motto? “If it’s shiny and seals tight, we make it right.”
The company’s ISO 9001:2015-certified plant ensures they meet pharmaceutical-grade standards. The new Ahmedabad plant adds redundancy and scale — a smart move given the company’s FY26 revenue target of ₹230–250 crore, as mentioned in their investor call.
